Vera Therapeutics, Inc. (VERA)

NASDAQ: VERA · IEX Real-Time Price · USD

42.32

+2.81 (7.11%)

At close: May 1, 2024, 4:00 PM

43.64

+1.32 (3.12%)

After-hours: May 1, 2024, 7:56 PM EDT

Vera Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-95.99	-89.06	-32.61	-53.41	-11.85
Depreciation & Amortization	-1.86	1.43	0.18	0.25	0.51
Share-Based Compensation	11.49	8.89	3.01	0.33	0.26
Other Operating Activities	-5.82	11.15	5.71	18.02	0.79
Operating Cash Flow	-92.18	-67.6	-23.71	-34.81	-10.29
Capital Expenditures	-0.06	-0.06	0	-0.04	-0.13
Acquisitions	0	0	-4.2	0	0
Change in Investments	-39.37	-70.49	0	0	0
Investing Cash Flow	-39.43	-70.55	-4.2	-0.04	-0.13
Share Issuance / Repurchase	116.06	88.21	51.73	0.23	0.05
Debt Issued / Paid	24.74	19.82	4.92	5.45	-0.19
Other Financing Activities	-7.26	-6.1	-2.77	79.61	-
Financing Cash Flow	133.54	101.93	53.88	85.29	-0.14
Net Cash Flow	1.93	-36.22	25.97	50.44	-10.55
Free Cash Flow	-92.24	-67.66	-23.71	-34.85	-10.41
Free Cash Flow Per Share	-2.16	-2.55	-1.76	-108.92	-35.26

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).